Roswell Biotechnologies is a life sciences company that develops and commercializes molecular electronics biosensors for DNA sequencing and diagnostics. The company's proprietary technology platform, ReZolve, is a single-molecule biosensor that enables direct, electronic detection of DNA sequences. The technology is expected to revolutionize the field of DNA sequencing and diagnostics by providing faster, more accurate, and more cost-effective results than current methods. Roswell Biotechnologies was founded in 2014 and is headquartered in San Diego, California.